Disturbed Neurovascular Coupling in Patients with White Matter Hyperintensities: Potential Biomarker for Cognitive Impairment

Overview

Journal Neuroradiology

Specialties Neurology
Radiology

Date 2024 Nov 30

PMID 39616265

Authors

Hui Li

Chao Chai

Yuanliang Xie

Huiying Wang

Xuedong Bai

You Li

Qin Zhong

Mingze Xu

Xiang Wang

Shuang Xia

Affiliations

Soon will be listed here.

Abstract

Purpose: To explore the neurovascular mechanisms of white matter hyperintensities (WMHs)-related cognitive impairment by introducing a neurovascular biomarker, neurovascular coupling (NVC).

Methods: We applied resting-state functional magnetic resonance imaging combined with arterial spin labeling to investigate the NVC dysfunctional patterns in patients with pure WMHs. Partial correlation, mediation, and exploratory subgroup analyses were adopted to explore the relationship among WMHs, NVC dysfunction, and cognitive decline.

Results: We found 21 brain regions with NVC dysfunction in patients with pure WMHs, mainly distributed in the default mode network, dorsal attention network, subcortical nucleus, and limbic system (p < 0.0125, Bonferroni correction). The NVC dysfunction of brain regions in the subcortical nucleus and limbic system correlated with the total WMHs burden and paraventricular WMHs burden (q < 0.05, FDR correction). The reduced NVC of the left amygdala partially mediated the impact of paraventricular WMHs on executive function (Mediation effect: -0.117; 95%CI: -4.042,-0.011; p < 0.05). Among the WMHs subjects without cognitive impairment, the increased NVC of the left basal ganglia significantly correlated with the MoCA score (r = 0.539, p < 0.05).

Conclusion: These findings reveal an underlying neurovascular mechanism of WMHs-related cognitive impairment. The neurovascular functions of the left amygdala and left basal ganglia may involve cognitive damage and compensation, respectively, and can be used as potential biomarkers and therapeutic targets for cognitive impairment in patients with WMHs.

References

Georgakis M, Duering M, Wardlaw J, Dichgans M . WMH and long-term outcomes in ischemic stroke: A systematic review and meta-analysis. Neurology. 2019; 92(12):e1298-e1308. DOI: 10.1212/WNL.0000000000007142. View

Pantoni L . Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010; 9(7):689-701. DOI: 10.1016/S1474-4422(10)70104-6. View

de Leeuw F, de Groot J, Oudkerk M, Witteman J, Hofman A, van Gijn J . Hypertension and cerebral white matter lesions in a prospective cohort study. Brain. 2002; 125(Pt 4):765-72. DOI: 10.1093/brain/awf077. View

Debette S, Markus H . The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010; 341:c3666. PMC: 2910261. DOI: 10.1136/bmj.c3666. View

Hu H, Ou Y, Shen X, Qu Y, Ma Y, Wang Z . White matter hyperintensities and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 36 prospective studies. Neurosci Biobehav Rev. 2020; 120:16-27. DOI: 10.1016/j.neubiorev.2020.11.007. View

Dufouil C, Godin O, Chalmers J, Coskun O, MacMahon S, Tzourio-Mazoyer N . Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history. Stroke. 2009; 40(6):2219-21. DOI: 10.1161/STROKEAHA.108.540633. View

van Dijk E, Prins N, Vrooman H, Hofman A, Koudstaal P, Breteler M . Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke. 2008; 39(10):2712-9. DOI: 10.1161/STROKEAHA.107.513176. View

van Leijsen E, Bergkamp M, van Uden I, Ghafoorian M, van der Holst H, Norris D . Progression of White Matter Hyperintensities Preceded by Heterogeneous Decline of Microstructural Integrity. Stroke. 2018; 49(6):1386-1393. DOI: 10.1161/STROKEAHA.118.020980. View

Tuladhar A, van Dijk E, Zwiers M, van Norden A, de Laat K, Shumskaya E . Structural network connectivity and cognition in cerebral small vessel disease. Hum Brain Mapp. 2015; 37(1):300-10. PMC: 6867512. DOI: 10.1002/hbm.23032. View

10.

Jaywant A, Dunlop K, Victoria L, Oberlin L, Lynch C, Respino M . Estimated Regional White Matter Hyperintensity Burden, Resting State Functional Connectivity, and Cognitive Functions in Older Adults. Am J Geriatr Psychiatry. 2021; 30(3):269-280. PMC: 8799753. DOI: 10.1016/j.jagp.2021.07.015. View

11.

Acharya A, Liang X, Tian W, Jiang C, Han Y, Yi L . White Matter Hyperintensities Relate to Basal Ganglia Functional Connectivity and Memory Performance in aMCI and SVMCI. Front Neurosci. 2019; 13:1204. PMC: 6874172. DOI: 10.3389/fnins.2019.01204. View

12.

Hu Y, Yang Y, Hou X, Zhou Y, Nie S . The influence of white matter hyperintensities severity on functional brain activity in cerebral small vessel disease: An rs-fMRI study. J Xray Sci Technol. 2022; 30(6):1213-1227. DOI: 10.3233/XST-221218. View

13.

Kuroda T, Ono K, Honma M, Asano M, Mori Y, Futamura A . Cerebral white matter lesions and regional blood flow are associated with reduced cognitive function in early-stage cognitive impairment. Front Aging Neurosci. 2023; 15:1126618. PMC: 9978183. DOI: 10.3389/fnagi.2023.1126618. View

14.

Shi L, Miao X, Lou W, Liu K, Abrigo J, Wong A . The Spatial Associations of Cerebral Blood Flow and Spontaneous Brain Activities with White Matter Hyperintensities-An Exploratory Study Using Multimodal Magnetic Resonance Imaging. Front Neurol. 2017; 8:593. PMC: 5684108. DOI: 10.3389/fneur.2017.00593. View

15.

Huang H, Zhao K, Zhu W, Li H, Zhu W . Abnormal Cerebral Blood Flow and Functional Connectivity Strength in Subjects With White Matter Hyperintensities. Front Neurol. 2021; 12:752762. PMC: 8564178. DOI: 10.3389/fneur.2021.752762. View

16.

Iadecola C . The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease. Neuron. 2017; 96(1):17-42. PMC: 5657612. DOI: 10.1016/j.neuron.2017.07.030. View

17.

Phillips A, Chan F, Zi Zheng M, Krassioukov A, Ainslie P . Neurovascular coupling in humans: Physiology, methodological advances and clinical implications. J Cereb Blood Flow Metab. 2015; 36(4):647-64. PMC: 4821024. DOI: 10.1177/0271678X15617954. View

18.

Canna A, Esposito F, Tedeschi G, Trojsi F, Passaniti C, Di Meo I . Neurovascular coupling in patients with type 2 diabetes mellitus. Front Aging Neurosci. 2022; 14:976340. PMC: 9476313. DOI: 10.3389/fnagi.2022.976340. View

19.

Li P, Mu J, Ma X, Ding D, Ma S, Zhang H . Neurovascular coupling dysfunction in end-stage renal disease patients related to cognitive impairment. J Cereb Blood Flow Metab. 2021; 41(10):2593-2606. PMC: 8504946. DOI: 10.1177/0271678X211007960. View

20.

Li P, Ma S, Ma X, Ding D, Zhu X, Zhang H . Reversal of neurovascular decoupling and cognitive impairment in patients with end-stage renal disease during a hemodialysis session: Evidence from a comprehensive fMRI analysis. Hum Brain Mapp. 2022; 44(3):989-1001. PMC: 9875915. DOI: 10.1002/hbm.26122. View